Efficacy and Safety of Tacrolimus Sustained-release Capsules in Induction Treatment in Refractory Lupus Nephritis.

Trial Profile

Efficacy and Safety of Tacrolimus Sustained-release Capsules in Induction Treatment in Refractory Lupus Nephritis.

Completed
Phase of Trial: Phase III

Latest Information Update: 02 Nov 2011

At a glance

  • Drugs Tacrolimus (Primary)
  • Indications Lupus nephritis
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 02 Nov 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 02 Nov 2011 Actual end date (Oct 2011) added as reported by ClinicalTrials.gov.
    • 08 Apr 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top